GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study sugges ...

Patients with T2D who undergo kidney transplants are less likely to experience organ failure and mortality if they receive ...

Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before ...

The commercial success of the injectable peptide-based weight-loss drugs marketed by Novo Nordisk and Eli Lilly and Company ...

Whoopi Goldberg has stunned in her latest looks showing off her 100+ pound weight loss after taking popular weight loss drug ...

Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before ...

Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within 1 year.

GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.

Insulin resistance in T1D is more common than you think, and without early intervention, these patients face increased risks ...

A Stanford Medicine study taps artificial intelligence to find a naturally occurring molecule called a peptide that ...

A product development expert explains how the swift rise of these anti-obesity medications is fueling new food trends.

Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with ...